R&D Longevity studies in life sciences today Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.
R&D A complex biological landscape of protein function unlocked ... Promise Bio’s advanced AI-driven system integrates proteomics and multi-omics data, focusing on PTMs to identify unique biomarkers % disease pathways.
Digital Israel’s MedTech and health innovation landscape: Part One –... Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.
Digital Leveraging data and AI for clinical trial success Over 90% of experimental therapies that reach human trials fail to make it to market.
News Israel says Pfizer jab less effective against COVID-19 delta The Israeli Ministry of Health has reported data suggesting that the efficacy of the Pfizer/BioNTech COVID-19 vaccine has become less effective at preventing the spread of the coronavirus a
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
